IMC Chicago’s ProShares UltraShort Health Care RXD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.24M | Buy |
64,000
+20,900
| +48% | +$412K | ﹤0.01% | 2915 |
|
|
2026
Q1 | $3.03M | Buy |
43,100
+8,700
| +25% | +$160K | ﹤0.01% | 2210 |
|
|
2025
Q4 | $2.4M | Sell |
34,400
-24,400
| -41% | -$479K | ﹤0.01% | 2262 |
|
|
2025
Q3 | $3.97M | Sell |
58,800
-21,950
| -27% | -$530K | ﹤0.01% | 1736 |
|
|
2025
Q2 | $5.67M | Buy |
80,750
+30,350
| +60% | +$742K | ﹤0.01% | 1314 |
|
|
2025
Q1 | $3.39M | Buy |
50,400
+8,450
| +20% | +$182K | ﹤0.01% | 1449 |
|
|
2024
Q4 | $3.07M | Sell |
41,950
-59,700
| -59% | -$1.27M | ﹤0.01% | 1548 |
|
|
2024
Q3 | $3.79M | Buy |
101,650
+8,300
| +9% | +$163K | ﹤0.01% | 1271 |
|
|
2024
Q2 | $4.47M | Sell |
93,350
-219,050
| -70% | -$4.8M | ﹤0.01% | 1117 |
|
|
2024
Q1 | $7.27M | Buy |
312,400
+92,300
| +42% | +$2.01M | ﹤0.01% | 829 |
|
|
2023
Q4 | $8.45M | Sell |
220,100
-12,200
| -5% | -$322K | 0.01% | 708 |
|
|
2023
Q3 | $8.95M | Buy |
232,300
+1,000
| +0.4% | +$25.1K | 0.01% | 582 |
|
|
2023
Q2 | $7.34M | Sell |
231,300
-18,100
| -7% | -$458K | 0.01% | 576 |
|
|
2023
Q1 | $9.16M | Sell |
249,400
-48,450
| -16% | -$1.24M | 0.01% | 512 |
|
|
2022
Q4 | $14.3M | Sell |
297,850
-116,600
| -28% | -$2.96M | 0.02% | 375 |
|
|
2022
Q3 | $21.4M | Buy |
414,450
+127,100
| +44% | +$3.43M | 0.03% | 271 |
|
|
2022
Q2 | $13.9M | Sell |
287,350
-7,100
| -2% | -$193K | 0.02% | 364 |
|
|
2022
Q1 | $10.6M | Buy |
294,450
+31,650
| +12% | +$857K | 0.01% | 453 |
|
|
2021
Q4 | $8.51M | Buy |
+262,800
| New | +$6.97M | 0.01% | 510 |
|
|
2021
Q3 | – | Sell |
-54,400
| Closed | -$1.88M | – | 1260 |
|
|
2021
Q2 | $1.88M | Buy |
54,400
+41,150
| +311% | +$1.31M | ﹤0.01% | 796 |
|
|
2021
Q1 | $888K | Sell |
13,250
-108,100
| -89% | -$3.91M | ﹤0.01% | 869 |
|
|
2020
Q4 | $3.81M | Buy |
121,350
+60,950
| +101% | +$2.57M | ﹤0.01% | 605 |
|
|
2020
Q3 | $2.83M | Buy |
60,400
+14,225
| +31% | +$677K | ﹤0.01% | 522 |
|
|
2020
Q2 | $3.08M | Buy |
46,175
+37,700
| +445% | +$2.16M | 0.01% | 465 |
|
|
2020
Q1 | $545K | Sell |
8,475
-32,325
| -79% | -$2.38M | ﹤0.01% | 723 |
|
|
2019
Q4 | $4.33M | Buy |
+40,800
| New | +$3.23M | 0.01% | 369 |
|
|
2019
Q1 | – | Sell |
-16,600
| Closed | -$2.33M | – | 851 |
|
|
2018
Q4 | $2.33M | Buy |
+16,600
| New | +$1.59M | 0.01% | 318 |
|
Other funds holding RXD
IMC Chicago's RXD Position: Q2 2026 in Review
IMC Chicago increased its ProShares UltraShort Health Care (RXD) stake by 22% in Q2 2026, buying an estimated $45.4K and bringing the position to 12,592 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #5604.
IMC Chicago first reported a position in RXD in Q2 2023 and has held it in 5 quarters since. The position peaked at $271K in Q2 2025. 3 funds tracked by Wall St. Rank hold RXD as of Q2 2026.
- IMC Chicago held 12,592 shares of ProShares UltraShort Health Care worth $214K as of Q2 2026.
- IMC Chicago bought 2,301 ProShares UltraShort Health Care shares in Q2 2026, an estimated $45.4K.
- ProShares UltraShort Health Care made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5604 holding.
- IMC Chicago first reported a position in ProShares UltraShort Health Care in Q2 2023 and has held it in 5 quarters since.
- IMC Chicago's ProShares UltraShort Health Care position peaked at $271K in Q2 2025.
- 3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q2 2026.
Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.